Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron
Siling Wang(Xiamen University), Ningshao Xia(Xiamen University), Hualong Xiong(Xiamen University), Qingbing Zheng(Xiamen University), Xiuting Chen(Xiamen University), Shaojuan Wang(Xiamen University), Yang Huang(Xiamen University), Yi Guan(Tianjin Medical University Eye Hospital), Hai Yu(Xiamen University), Ying Dong(Xiamen University), Lunzhi Yuan(Xiamen University), Zimin Tang(Xiamen University), Zizheng Zheng(Xiamen University), Quan Yuan(Xuzhou Medical College), Chang Liu(Paul Scherrer Institute), Yali Zhang(Xiamen University), Tingting Li(Peking University First Hospital), Jun Zhang(Army Medical University), Zihao Chen(Xiamen University), Yizhen Wang(Xi'an University of Science and Technology), Shaowei Li(Xiamen University), Hui Sun(Heilongjiang University of Chinese Medicine), Jinlei Zhang(Suzhou University of Science and Technology), Tianying Zhang(Guangdong Medical College), Tong Cheng(Xiamen University), Liqin Liu(Xinjiang Agricultural University)
Cited by 36
Related Papers
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
|Nature Medicine|2006|1.9k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
|Science|2013|1.2k